The global enteral feeding devices market size was valued at USD 3.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. The market growth is fuelled by the increasing prevalence of chronic diseases and malnutrition, rising demand from the home care sector, and the growing geriatric population. The rise in the geriatric population with chronic conditions such as organ failure, multiple sclerosis, stroke, and dementia that impact swallowing in patients is further increasing the demand for nutritional feeding through enteral feeding devices. The population with multiple sclerosis, stroke, and dementia is a major target population for the market.
For instance, according to the NCBI, as per a U.S. survey, about 34% of the 186,835 patients in nursing homes required tube feeding as the patients with dementia have poor nutritional requirements. This factor is contributing to a significant increase in the demand for enteral feeding devices. Stroke can also be a cause of malnutrition in patients, thereby increasing the demand for enteral feeding devices. As per the articles of the NCBI, it was estimated that the prevalence of malnutrition in patients with stroke may range from 8% to 34%.
The increasing pediatric population suffering from malnutrition is a key factor fueling the market growth. Children with malnutrition require nutritional supplements through enteral feeding for the ones that have swallowing difficulties. Malnutrition is a major burden on society that creates the need for feeding devices for patients that have metabolic and gastrointestinal disorders. According to a survey, 40% of hospitalized patients suffer from malnourishment, which increases the risk of morbidity and mortality. Thus, for these patients, enteral feeding is the first choice to provide adequate nutrients for the ones that are unable to take the nutrients.
Enteral feeding devices have been used predominantly to support patients having neck and head cancer where they have reduced oral intake due to difficulty in swallowing, which further causes poor nutritional status among the patients. Therefore, to meet the nutritional requirements of patients, enteral feeding is the preferred choice to provide nutrients. According to the data published by the American Society of Clinical Oncology, in 2020, more than 560,000 patients were diagnosed with neck and head cancer. Furthermore, the rising number of premature births in developing countries such as India and China has contributed to the increase in the need for enteral feeding devices during the forecast period. Prematurely born children require vitamins and minerals for their optimal growth that is given through enteral feeding devices, thereby propelling the market growth.
The COVID-19 pandemic had a positive impact on the market growth as the rate of hospitalization increased considerably, which increased the demand for enteral feeding devices for critically ill patients. The critically ill patients had reduced oral intake due to nausea, anorexia, and impairment of taste, thereby increasing the need for enteral feeding devices to provide nourishment. The key players tried to manage their products to meet the increasing demand for enteral devices for critically ill patients. For instance, in the U.K., Abbott managed its pump resources by checking the number of pumps that were used and the ones that were not. The hospitals having stock of pumps greater than required were recalled and redistributed to other hospitals.
The lack of awareness and understanding regarding EN in the medical fraternity is expected to limit its adoption. Furthermore, not all medical experts are convinced that EN-based formulas would be successful in the treatment of health-related or chronic conditions and their allied symptoms, which may negatively impact the adoption of these products along with treatment. However, rising government and other initiatives to spread awareness regarding the importance of nutrient intake among the patient population are anticipated to improve the current market scenario. In addition, manufacturers must focus on raising awareness about these products among physicians and end-users, which would help surge their adoption.
In 2021, the enteral feeding pump segment held the largest revenue share of over 40.0%. Enteral-based feeding or nutrition is common for the pediatric and adult population that are diagnosed with chronic diseases to improve the nutritional uptake and prevent malnutrition that is common as these conditions reduce the oral intake of nutrition, which further drives the segment. The growth of this segment can also be attributed to the rising adoption of such devices for home care and hospital as they are safe and dispense an appropriate amount of nutrition. In addition, the introduction of technologically advanced devices propels market growth. For instance, the introduction of closed systems for the pumps has reduced the microbial risk and enhanced the usability of the product.
The low-profile gastronomy device segment is anticipated to register the fastest CAGR of 6.0% during the forecast period owing to the higher adoption of low-profile gastronomy devices in the pediatric and geriatric population. Compact designs and aesthetic appearance are some of the factors contributing to the market growth. The low-profile gastronomy tubes help to provide nutrition to the patients for a longer time as compared to other gastronomy tubes, thereby increasing their adoption.
North America held the largest revenue share of over 35.0% in 2021. The growth of the regional market can be attributed to the presence of a large geriatric population dealing with chronic diseases. For instance, as per the data published by the Centers for Disease Control and Prevention, on average, 85% of the older population deal with at least 1 chronic disease, and 60% have at least two chronic disorders.
Furthermore, the rising penetration of cancer, Alzheimer’s disease, and other lifestyle disorders increase the demand for enteral feeding devices. Increasing awareness regarding the use of enteral feeding devices, growing requirements for radiotherapy procedures and reconstructive surgeries, and effective reimbursement policies are some of the major factors that have increased the regional demand.
The Asia Pacific region is projected to register the fastest CAGR of 5.5% in the forecast period. Growing healthcare infrastructure and the introduction of advanced medical equipment are expected to fuel the market growth. Furthermore, the increasing percentage of hospital admissions, preterm births, malnourished population, and geriatric population are some of the key factors that drive the market. As per the article published by The Lancet Global Health, there are more than 1 million preterm births every year in China. Furthermore, a gradual shift to enteral nutrition from parenteral further pushes the market growth.
Enteral feeding devices are increasingly being adopted for patients that have swallowing disorders due to medical conditions such as dementia and stroke and for the pediatric population suffering from malnutrition. Furthermore, strategic initiatives such as partnerships, mergers & acquisitions, collaborations, and product launches are being undertaken by key players to increase their market share.
For instance, in February 2022, Amsino Medical Group announced FDA clearance for the PuggleEnteral Feeding Pump and Set, which is intended to deliver nutrition for both the pediatric and geriatric populations. Such initiatives will help in supporting the market growth over the forecast period. Some prominent players in the global enteral feeding devices market include:
Kimberly-Clark Corporation
Abbott Nutrition
Boston Scientific Corporation
Amsino International Inc.
ConMed Corporation
Moog Inc
C.R.Bard
Danone
Cook Medical
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
Avanos Medical Inc.
Cardinal Health Inc.
Vygon SA
Applied Medical Technology Inc.
Fidmi Medical
ALCOR Scientific Inc.
Report Attribute |
Details |
Market size value in 2022 |
USD 4.0 billion |
Revenue forecast in 2030 |
USD 5.7 billion |
Growth Rate |
CAGR of 4.7% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2016 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, age group, indication, end user and region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Kimberly-Clark Corporation; Abbott Nutrition; Boston Scientific Corporation; Amsino International Inc.; ConMed Corporation; Moog Inc.; C.R.Bard; Danone; Cook Medical, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Avanos Medical Inc., Cardinal Health Inc., Vygon SA, Applied Medical Technology Inc., Fidmi Medical, ALCOR Scientific Inc. |
Customization scope |
Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2030. For this study, Grand View Research, Inc. has segmented the global enteral feeding devices market report on the basis of product, age group, indication, end user and region:
Enteral Feeding Devices Product Type Outlook (Revenue, USD Million, 2016 - 2030)
Giving Set
Enteral Feeding Pump
Percutaneous Endoscopic Gastrostomy Device
Low Profile Gastrostomy Device
Nasogastric Tube
Gastrostomy Tube
Enteral Feeding Devices Age Group Outlook (Revenue, USD Million, 2016 - 2030)
Pediatrics
Adults
Enteral Feeding Devices Indication Outlook (Revenue, USD Million, 2016 - 2030)
Alzheimer’s
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
Enteral Feeding Devices End-user Outlook (Revenue, USD Million, 2016 - 2030)
Hospitals
Cardiology
Neurology
Critical Care (ICU)
Oncology
Others
Home Care
Regional Outlook (Revenue, USD Million, 2016 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
b. The global enteral feeding devices market size was estimated at USD 3.9 billion in 2021 and is expected to reach USD 4.0 billion in 2022.
b. The global enteral feeding devices market is expected to grow at a compound annual growth rate of 4.7% from 2022 to 2030 to reach USD 5.7 billion by 2030.
b. North America dominated the enteral feeding devices market with a share of 37.5% in 2021. This is attributable to the increasing prevalence of lifestyle diseases, the increasing geriatric population prone to chronic diseases.
b. Some key players operating in the enteral feeding devices market include Kimberly-Clark Corporation; Abbott Nutrition;Boston Scientific Corporation;Amsino International Inc.; ConMed Corporation; Moog Inc.; C.R.Bard; Danone; and Cook Medical.
b. Key factors that are driving the enteral feeding devices market growth include growing demand from the home care sector, the prevalence of chronic diseases, the incidence of preterm birth, and the growing geriatric population.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.